Pay in 4 interest-free payments of $28.98 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Studies indicate that ATP production is shifted towards glucose oxidation by Ranolazine
the MTT assay is performed
10-diazatricyclo[6
DTXSID80438322
InChi: InChI=1S/C12H8Cl2N2O/c13-9-3-1-8(2-4-9)12(17)16-10-5-6-11(14)15-7-10/h1-7H
VX-661 Catalog No.:M10067-10 Studies indicate that ATP productionTezacaftor, also known asVX 661, is CFTR modulator. VX 661 is potentially useful for treatment of cystic fibrosis disease. Cystic fibrosis (CF) is a genetic disease caused by defects in the CF transmembrane regulator (CFTR) gene, which encodes an epithelial chloride channel. The most common mutation, 508CFTR, produces a protein that is misfolded and does not reach the cell membrane. VX 661 can correct trafficking of 508CFTR and partially restore
US$ 65273.00
US$ 54343.00
US$ 44406.50
US$ 55512.50
US$ 28000.00
US$ 66497.00